ROARABLE // PRO
GLOBAL DESKS // NYC --:--:-- NYSE
US TAPE
ROAR ▸
COMP <GO>

RNXT vs GOSS // FREE CASH FLOW YIELD

RenovoRx Inc. (NASDAQ) VS. Gossamer Bio Inc. (NASDAQ) • 15-METRIC TALLY: RNXT 3 — GOSS 1
■ METRIC PARITY
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (RNXT VS. GOSS) EMERALD CELL = QUANTITATIVE EDGE
INSTITUTIONAL METRIC RNXT GOSS SPREAD (A - B) ADVANTAGE DEDICATED URL
Gross Profit Margin 70.90% — — TIE /gross-margins <GO>
Return on Invested Capital (ROIC) -35.00% -35.00% 0.00 TIE /roic <GO>
EV/EBITDA & P/E Valuation — — — TIE /valuation <GO>
Free Cash Flow Yield ACTIVE -16.32% — — TIE /fcf-yield <GO>
Operating Margin -60.00% -60.00% 0.00 TIE /operating-margins <GO>
Net Profit Margin -60.00% -60.00% 0.00 TIE /net-margins <GO>
Revenue Growth (YoY) 180.00% -57.70% +237.70 RNXT /revenue-growth <GO>
Dividend Yield & FCF Payout Safety 0.00% 0.00% 0.00 TIE /dividend-safety <GO>
Altman Z-Score & Debt/Equity 0.40 — — TIE /balance-sheet <GO>
Piotroski F-Score Quality 4/9 1/9 +3.00 RNXT /piotroski-score <GO>
Options Implied Move & Put/Call Skew — — — TIE /options-implied-move <GO>
RSI-14 & 200D SMA Momentum 47.1 51.3 -4.20 GOSS /rsi-technicals <GO>
10Y Yield & FRED Macro Beta — — — TIE /macro-sensitivity <GO>
Forward P/E Multiple — — — TIE /forward-pe <GO>
Enterprise Scale & Market Cap $67.2M $65.4M $1.9M RNXT /market-cap <GO>
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
FISCAL YEAR RNXT REV GOSS REV RNXT GROSS % GOSS GROSS % RNXT FCF GOSS FCF
FY 2025 $1.1M $48.5M 70.9% — -$11.0M -$171.3M
FY 2024 $43.0K $114.7M 98.0% — -$9.1M -$3.5M
FY 2023 $0 $0 — — -$10.3M -$159.2M
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
RNXT // BETA —
GOSS // BETA —